-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, VClEgOB2yU1QYxQ1A36MmjhDAWP02VmVH6IT8+WiPJiGJLY0axgoq8Sg9DEs+ftU EdbbJ337d3s5fVlwbunzkA== 0001399490-10-000021.txt : 20101112 0001399490-10-000021.hdr.sgml : 20101111 20101112134021 ACCESSION NUMBER: 0001399490-10-000021 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20100930 FILED AS OF DATE: 20101112 DATE AS OF CHANGE: 20101112 EFFECTIVENESS DATE: 20101112 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Redmile Group, LLC CENTRAL INDEX KEY: 0001425738 IRS NUMBER: 208592298 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-12776 FILM NUMBER: 101185198 BUSINESS ADDRESS: STREET 1: 100 PINE STREET, SUITE 1925 CITY: SAN FRANCISCO STATE: CA ZIP: 94111 BUSINESS PHONE: 415-489-9980 MAIL ADDRESS: STREET 1: 100 PINE STREET, SUITE 1925 CITY: SAN FRANCISCO STATE: CA ZIP: 94111 13F-HR 1 redq310new.txt REDMILE GROUP, LLC UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 13F Form 13F COVER PAGE Report for the Calendar Year or Quarter Ended: September 30, 2010 Check here if Amendment [ ]; Amendment Number: This Amendment (Check only one.): [ ] is a restatement. [ ] adds new holdings entries. Institutional Investment Manager Filing this Report: Name: Redmile Group, LLC Address: 100 Pine Street, Suite #1925 San Francisco, CA 94111 13F File Number: 28-12776 The institutional investment manager filing this report and the person by whom it is signed hereby represent that the person signing the report is authorized to submit it, that all information contained herein is true, correct and complete, and that it is understood that all required items, statements, schedules, lists, and tables, are considered integral parts of this form. Person Signing this Report on Behalf of Reporting Manager: Name: Jeremy Green Title: Managing Member Phone: 415-489-9980 Signature, Place, and Date of Signing: Jeremy Green San Francisco, CA October 11, 2010 Report Type (Check only one.): [ X] 13F HOLDINGS REPORT. [ ] 13F NOTICE. [ ] 13F COMBINATION REPORT. FORM 13F SUMMARY PAGE Report Summary: Number of Other Included Managers: 0 Form13F Information Table Entry Total: 34 Form13F Information Table Value Total: $175,015 (thousands) List of Other Included Managers: Provide a numbered list of the name(s) and Form 13F file number(s) of all institutional managers with respect to which this report is filed, other than the manager filing this report. NONE FORM 13F INFORMATION TABLE VALUE SHARES/ SH/ PUT/ INVSTMT OTHER VOTING AUTHORITY NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DSCRETN MANAGERS SOLE SHARED NONE - ------------------------------ ---------------- --------- -------- -------- --- ---- ------- ------------ -------- -------- -------- AETNA INC NEW COM 00817Y108 5845 184900 SH DEFINED 184900 ALIGN TECHNOLOGY INC COM 016255101 8186 418100 SH DEFINED 418100 ANTHERA PHARMACEUTICALS INC COM 03674U102 1743 416059 SH DEFINED 416059 ARDEA BIOSCIENCES INC COM 03969P107 3427 149017 SH DEFINED 149017 ARIAD PHARMACEUTICALS INC COM 04033A100 5685 1488150 SH DEFINED 1488150 ARTHROCARE CORP COM 043136100 2359 86801 SH DEFINED 86801 BIODEL INC COM 09064M105 1782 336200 SH DEFINED 336200 BIOMIMETIC THERAPEUTICS INC COM 09064X101 7070 620150 SH DEFINED 620150 BIOSPECIFICS TECHNOLOGIES CO COM 090931106 4756 176672 SH DEFINED 176672 CONMED CORP COM 207410101 2327 103841 SH DEFINED 103841 DAVITA INC COM 23918K108 7283 105505 SH DEFINED 105505 FRESENIUS MED CARE AG&CO KGA SPONSORED ADR 358029106 457 7400 SH DEFINED 7400 GENZYME CORP COM 372917104 6456 91200 SH DEFINED 91200 HEARTWARE INTL INC COM 422368100 3463 50358 SH DEFINED 50358 HILL ROM HLDGS INC COM 431475102 7269 202548 SH DEFINED 202548 INCYTE CORP COM 45337C102 4559 285126 SH DEFINED 285126 LEMAITRE VASCULAR INC COM 525558201 2190 310696 SH DEFINED 310696 MAP PHARMACEUTICALS INC COM 56509R108 3060 200000 SH DEFINED 200000 MICROMET INC COM 59509C105 5275 784900 SH DEFINED 784900 NEKTAR THERAPEUTICS COM 640268108 8271 559986 SH DEFINED 559986 NXSTAGE MEDICAL INC COM 67072V103 6616 346400 SH DEFINED 346400 ONYX PHARMACEUTICALS INC COM 683399109 12082 458000 SH DEFINED 458000 ORTHOFIX INTL N V COM N6748L102 11011 350450 SH DEFINED 350450 PROTALIX BIOTHERAPEUTICS INC COM 74365A101 5428 624600 SH DEFINED 624600 SAVIENT PHARMACEUTICALS INC COM 80517Q100 1242 54300 SH DEFINED 54300 SEQUENOM INC COM NEW 817337405 12925 1843800 SH DEFINED 1843800 STRYKER CORP COM 863667101 3263 65200 SH DEFINED 65200 TENET HEALTHCARE CORP COM 88033G100 487 103100 SH DEFINED 103100 TOMOTHERAPY INC COM 890088107 3611 1025872 SH DEFINED 1025872 UNITED THERAPEUTICS CORP DEL COM 91307C102 8682 155000 SH DEFINED 155000 UNITEDHEALTH GROUP INC COM 91324P102 5895 167900 SH DEFINED 167900 XENOPORT INC COM 98411C100 3547 498900 SH DEFINED 498900 YM BIOSCIENCES INC COM 984238105 1308 774000 SH DEFINED 774000 ZYMOGENETICS INC COM 98985T109 7455 764600 SH DEFINED 764600
-----END PRIVACY-ENHANCED MESSAGE-----